LEXARIA BIOSCIENCE CORP. (LEXX) Gross margin 2016–2025
LEXARIA BIOSCIENCE CORP. (LEXX) gross margin by fiscal year — reported gross profit divided by reported revenue.
99.6%FY2025 · since FY2016: -12.0% → 99.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 99.6% | +0.7 pp |
| FY2024 | 99.0% | +12.9 pp |
| FY2023 | 86.1% | +14.2 pp |
| FY2022 | 71.9% | -3.9 pp |
| FY2021 | 75.7% | +19.7 pp |
| FY2020 | 56.0% | -33.7 pp |
| FY2019 | 89.7% | -4.5 pp |
| FY2018 | 94.2% | +40.9 pp |
| FY2017 | 53.3% | +65.3 pp |
| FY2016 | -12.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LEXX financial trends
LEXX RevenueLEXX Net incomeLEXX Net marginLEXX Gross profitLEXX Operating incomeLEXX Operating marginLEXX Operating cash flowLEXX Free cash flowLEXX Capital expendituresLEXX Return on equityLEXX Stock buybacksLEXX Dividends paidLEXX Total assetsLEXX Total liabilitiesLEXX Shareholders’ equityLEXX overview →